| Literature DB >> 28358806 |
Rejane Pina Dantas Silva1,2, Bruna Aparecida Souza Machado2,3, Gabriele de Abreu Barreto2, Samantha Serra Costa1, Luciana Nalone Andrade4, Ricardo Guimarães Amaral4, Adriana Andrade Carvalho5, Francine Ferreira Padilha6, Josiane Dantas Viana Barbosa3, Marcelo Andres Umsza-Guez7.
Abstract
Propolis is known for its biological properties and its preparations have been continuously investigated in an attempt to solve the problem of their standardization, an issue that limits the use of propolis in food and pharmaceutical industries. The aim of this study was to evaluate in vitro antioxidant, antimicrobial, antiparasitic, and cytotoxic effects of extracts of red, green, and brown propolis from different regions of Brazil, obtained by ethanolic and supercritical extraction methods. We found that propolis extracts obtained by both these methods showed concentration-dependent antioxidant activity. The extracts obtained by ethanolic extraction showed higher antioxidant activity than that shown by the extracts obtained by supercritical extraction. Ethanolic extracts of red propolis exhibited up to 98% of the maximum antioxidant activity at the highest extract concentration. Red propolis extracts obtained by ethanolic and supercritical methods showed the highest levels of antimicrobial activity against several bacteria. Most extracts demonstrated antimicrobial activity against Staphylococcus aureus. None of the extracts analyzed showed activity against Escherichia coli or Candida albicans. An inhibitory effect of all tested ethanolic extracts on the growth of Trypanosoma cruzi Y strain epimastigotes was observed in the first 24 h. However, after 96 h, a persistent inhibitory effect was detected only for red propolis samples. Only ethanolic extracts of red propolis samples R01Et.B2 and R02Et.B2 showed a cytotoxic effect against all four cancer cell lines tested (HL-60, HCT-116, OVCAR-8, and SF-295), indicating that red propolis extracts have great cytotoxic potential. The biological effects of ethanolic extracts of red propolis revealed in the present study suggest that red propolis can be a potential alternative therapeutic treatment against Chagas disease and some types of cancer, although high activity of red propolis in vitro needs to be confirmed by future in vivo investigations.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28358806 PMCID: PMC5373518 DOI: 10.1371/journal.pone.0172585
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Propolis sample identification by the color, region, and state of origin.
| Identification | Color | Region | State of Origin |
|---|---|---|---|
| R01.B2 | Red | Northeast | Sergipe |
| R02.B2 | Red | Northeast | Alagoas |
| G01.B2 | Green | Southeast | Minas Gerais |
| G02.B2 | Green | Southeast | Minas Gerais |
| G03.B2 | Green | South | Paraná |
| B01.B2 | Brown | South | Santa Catarina |
| B02.B2 | Brown | South | Rio Grande do Sul |
| B03.B2 | Brown | South | Paraná |
Fig 1Determination of antioxidant activity of the propolis extracts from different regions of Brazil by the ABTS method, using four different concentrations (100, 500and 750 μm.mL-1), expressed as a percentage of antioxidant activity. Fig 1A –Extracts obtained by ethanolic extraction; Fig 1B –Extracts obtained by Supercritical extraction; Fig 1C –Comparison between red propolis extracts; Fig 1D—Comparison between green propolis extracts; Fig 1E—Comparison between brown propolis extracts.
Values showing different letter on the same concentration for different propolis extracts show significant difference (p>0.05) through the Tukey test at 95% confidence level. Et—Extracts obtained by ethanolic extraction. SC—Extracts obtained by Supercritical extraction. Average of analysis obtained in triplicate (n = 3).
Determination of Minimal Inhibitory Concentration (MIC) of extracts from different samples of Brazilian propolis obtained by Ethanolic extraction (Et) and by Supercritical fluid extraction (SC).
MIC is expressed as μg.mL-1.
| Extracts | |||||
|---|---|---|---|---|---|
| 62.5 | 125 | 62.5 | >1000 | >1000 | |
| 31.3 | 62.5 | 31.3 | >1000 | >1000 | |
| 250 | 500 | 500 | >1000 | >1000 | |
| 250 | >1000 | >1000 | >1000 | >1000 | |
| 250 | 250 | >1000 | >1000 | >1000 | |
| >1000 | >1000 | >1000 | >1000 | >1000 | |
| >1000 | >1000 | >1000 | >1000 | >1000 | |
| 500 | 1000 | >1000 | >1000 | >1000 | |
| 125 | 250 | 250 | >1000 | >1000 | |
| 62.5 | 125 | 62.5 | >1000 | >1000 | |
| >1000 | 250 | >1000 | >1000 | >1000 | |
| >1000 | 500 | >1000 | >1000 | >1000 | |
| >1000 | 250 | >1000 | >1000 | >1000 | |
| >1000 | >1000 | >1000 | >1000 | >1000 | |
| >1000 | >1000 | >1000 | >1000 | >1000 | |
| >1000 | >1000 | >1000 | >1000 | >1000 |
Minimal inhibitory concentration (MIC) of the red, green, and brown propolis extracts obtained by ethanolic extraction (Et) and by supercritical fluid extraction (SC) at concentrations from 31.3 to 1000 μg.mL-1.
Fig 2Activity of the EtOH extracts of different Brazilian propolis against Trypanosoma cruzi epimastigotes Y strains after 24 h (A) and 96 h (B) of incubation with both tested concentrations (75 and 300 mg.mL-1).
In vitro cytotoxicity of the EtOH red extracts on tumor cell lines.
Experiments were performed in triplicate.
| Samples μg/mL | HL-60 | HCT-116 | OVCAR-8 | SF-295 |
|---|---|---|---|---|
| 0.02 | 0.01 | 1.18 | 0.25 | |
| 0.01–0.02 | 0.01–0.03 | 0.92–1.51 | 0.16–0.35 | |
| 4.80 | 19.92 | 23.63 | 13.67 | |
| (3.97–5.82) | (14.40–27.56) | (19.66–28.40) | (11.22–16.65) | |
| 8.74 | 30.19 | 27.08 | 18.47 | |
| (7.66–9.95) | (21.91–41.59) | (24.67–29.72) | (15.10–22.59) |
Cell lines: OVCAR-8 (ovarian adenocarcinoma), HCT-116 (colon carcinoma), SF-295 (glioblastoma), and HL-60 (leukemia) humans. Data are presented as IC50 values (μg/mL), and their 95% confidence interval was obtained by non-linear regression from three independent experiments performed in triplicate, measured by the MTT assay after 72 h of incubation. Doxorubicin was used as the positive control.